Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 15-Apr-24 4:09 PM View:  | Apellis Pharmaceuticals, Inc. (APLS) | 12-Apr-24 | Option Exercise | 1,500 | $13.19 | $19,785.00 | < 1% 337.87K to 339.37K | |
| 20-Mar-24 5:18 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 19-Mar-24 | Private Sale | 18,681 | $57.18 | $1,068,160.00 | (5%) 356.55K to 337.87K | |
| 02-Jan-24 4:09 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 01-Jan-24 | Grant | 3,341 | -- | -- | < 1% 353.21K to 356.55K | |
| 15-Dec-23 4:04 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 14-Dec-23 | Option Exercise | 6,274 | $13.19 | $82,754.10 | 2% 346.94K to 353.21K | |
| 05-Dec-23 4:21 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 01-Dec-23 | Private Sale | 24,000 | $61.13 | $1,467,240.00 | (6%) 370.94K to 346.94K | |
| 21-Nov-23 4:36 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 17-Nov-23 | Private Sale | 8,894 | $49.99 | $444,620.00 | (2%) 379.83K to 370.94K | |
| 21-Nov-23 4:00 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 17-Oct-23 | Private Sale | 24,000 | $49.00 | $1,176,000.00 | (6%) 403.83K to 379.83K | |
| 05-Apr-23 4:54 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 03-Apr-23 | Private Sale (Planned) | 500 | $74.05 | $37,025.00 | (< 1%) 404.33K to 403.83K | |
| 02-Mar-23 4:20 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 01-Mar-23 | Private Sale (Planned) | 500 | $65.33 | $32,665.00 | (< 1%) 404.83K to 404.33K | |
| 02-Feb-23 4:15 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 01-Feb-23 | Private Sale (Planned) | 500 | $52.61 | $26,305.00 | (< 1%) 405.33K to 404.83K | |
| 05-Jan-23 7:40 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 03-Jan-23 | Private Sale (Planned) | 500 | $50.70 | $25,350.00 | (< 1%) 405.83K to 405.33K | |
| 04-Jan-23 5:35 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 01-Jan-23 | Grant | 3,867 | -- | -- | < 1% 401.96K to 405.83K | |
| 02-Dec-22 4:30 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 01-Dec-22 | Private Sale (Planned) | 500 | $49.93 | $24,965.00 | (< 1%) 402.46K to 401.96K | |
| 03-Nov-22 4:28 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 01-Nov-22 | Private Sale (Planned) | 500 | $60.83 | $30,415.00 | (< 1%) 402.96K to 402.46K | |
| 08-Sep-22 4:38 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 08-Sep-22 | Private Sale | 15,000 | $65.00 | $975,000.00 | (4%) 417.96K to 402.96K | |
| 26-Aug-22 4:06 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 25-Aug-22 | Option Exercise | 4,306 | $13.19 | $56,796.10 | 1% 413.66K to 417.96K | |
| 17-Aug-22 5:08 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 16-Aug-22 | Option Exercise | 25,394 | $14.00 | $355,516.00 | 7% 388.26K to 413.66K | |
| 12-Aug-22 4:57 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 11-Aug-22 | Private Sale | 30,000 | $65.63 | $1,968,900.00 | (7%) 418.26K to 388.26K | |
| 22-Jul-22 4:01 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Jul-22 | Option Exercise | 9,606 | $14.00 | $134,484.00 | 2% 408.66K to 418.26K | |
| 29-Jun-22 4:18 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 27-Jun-22 | Private Sale | 1,341 | $46.79 | $62,742.80 | (< 1%) 288.36K to 287.02K | |
| 24-Jun-22 5:15 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 23-Jun-22 | Market Sale | 15,000 | $45.00 | $675,000.00 | (5%) 300.68K to 285.68K | 1% |
| 25-Apr-22 9:35 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 22-Apr-22 | Option Exercise | 20,000 | $14.00 | $280,000.00 | 5% 403.66K to 423.66K | |
| 04-Jan-22 4:38 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 01-Jan-22 | Grant | 4,230 | -- | -- | 1% 367.57K to 371.8K | |
| 13-Sep-21 4:10 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 10-Sep-21 | Option Exercise | 6,894 | $14.00 | $96,516.00 | 2% 392.53K to 399.43K | |
| 02-Jun-21 4:23 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 01-Jun-21 | Acquisition (other) | 13,108 | -- | -- | 3% 392.53K to 405.64K | |
| 02-Jun-21 4:23 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 01-Jun-21 | Acquisition (other) | 2,682 | -- | -- | < 1% 405.64K to 408.32K | |
| 02-Jun-21 4:23 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 01-Jun-21 | Disposition (other) | 31,855 | -- | -- | (8%) 408.32K to 376.47K | |
| 20-May-21 4:53 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 20-May-21 | Market Sale | 5,773 | $48.10 | $277,681.00 | (2%) 338.31K to 332.53K | (18%) |
| 20-May-21 4:53 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 19-May-21 | Market Sale | 7,612 | $50.00 | $380,600.00 | (2%) 345.92K to 338.31K | (14%) |
| 20-May-21 4:53 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 18-May-21 | Market Sale | 149,488 | $52.85 | $7,899,850.00 | (30%) 495.41K to 345.92K | (8%) |
| 26-Apr-21 6:00 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 23-Apr-21 | Option Exercise | 10,000 | $14.00 | $140,000.00 | 2% 545.41K to 555.41K | |
| 19-Apr-21 7:29 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 16-Apr-21 | Option Exercise | 50,000 | $14.00 | $700,000.00 | 10% 495.41K to 545.41K | |
| 15-Dec-20 5:05 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 14-Dec-20 | Market Sale | 25,000 | $54.67 | $1,366,710.00 | (13%) 199.73K to 174.73K | (4%) |
| 07-Dec-20 6:58 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 07-Dec-20 | Market Sale | 18,564 | $50.71 | $941,399.00 | (9%) 218.29K to 199.73K | (12%) |
| 07-Dec-20 6:58 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 04-Dec-20 | Market Sale | 6,436 | $50.26 | $323,455.00 | (3%) 224.73K to 218.29K | (13%) |
| 20-Dec-19 5:11 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 20-Dec-19 | Market Sale | 25,000 | $29.53 | $738,250.00 | (4%) 570.41K to 545.41K | (93%) |
| 20-Dec-19 5:11 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 19-Dec-19 | Market Sale | 85,110 | $29.18 | $2,483,460.00 | (13%) 655.52K to 570.41K | (95%) |
| 20-Dec-19 5:11 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 18-Dec-19 | Market Sale | 25,890 | $28.55 | $739,160.00 | (4%) 681.41K to 655.52K | (99%) |
| 09-May-18 4:13 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 07-May-18 | Acquisition (other) | 94,357 | -- | -- | 16% 587.05K to 681.41K | |
| 13-Nov-17 4:29 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 13-Nov-17 | Conversion | 400,679 | -- | -- | 215% 186.37K to 587.05K |